Skip to main content
TrialFinder
ResourcesAbout
ⓘNot medical advice.▾

This site is for general information only and is not medical advice, diagnosis, or treatment. Always talk to a qualified clinician before medical decisions. TrialFinder is not affiliated with trial sponsors or healthcare providers.

Privacy policyTerms of useAccessibilityFAQFeedback
Support the project (opens in a new tab)

We use functional cookies to improve your experience. See our Privacy policy.

Trial data comes from ClinicalTrials.gov (US) and is shown for information only.

In memory of Dov Korn ❤️

Talking to Your Doctor About Trials | TrialFinder
HomeResourcesHow to Talk to Your Doctor About Clinical Trials

Back to Resources

Published · July 3, 2026· Updated September 12, 2026

How to Talk to Your Doctor About Clinical Trials

Bringing up the topic of clinical trials can feel challenging. In a previous guide, we discussed how to talk about clinical trials with your family members, but for many, the real hurdle is sitting in the clinic with their doctor.

Clinic visits are often short and doctors are incredibly busy. It can feel intimidating to "squeeze in" a new idea, especially if your doctor didn't suggest it first. But it's important to remember: participating in a clinical trial is a legitimate medical option, and exploring it is your right as an active partner in your healthcare journey.

This guide is designed to give you a practical toolkit for your next appointment, helping you raise the topic clearly, confidently, and with less unnecessary stress.

What to Know Before You Speak to Your Doctor

These points can help set the tone when you raise clinical trials with your care team:

  1. Don't wait for the "last resort": A common misconception is that clinical trials are only for when all other treatments have failed. In reality, many trials are designed as a "first-line therapy" or for early stages of a disease. It's best to bring up the topic early on when building your treatment plan. That said, it is also never too late to ask, whether you are newly diagnosed or in a later stage of your disease.
  2. Your doctor can't know every trial: Medical research is advancing at lightning speed. Even the most dedicated, up-to-date doctor cannot memorize every clinical trial opening locally or globally. When you come in with information you've gathered, you are helping them, not competing with them.
  3. Be prepared for a cautious response: Doctors are, by nature, methodical and cautious. If they initially hesitate when you suggest a clinical trial, it doesn't mean it's a bad idea. They might want to ensure the standard treatment is fully explored first, or they simply might need time to read the specific trial protocol you brought them. Treat hesitation as part of the process, not a closed door.

Having the Conversation

Here's how to approach it, step by step:

Step 1: Do Your Homework (and Bring Support)

Don't walk into the appointment with just a vague idea. Know your exact diagnosis, stage, prior treatments, and biomarker status. If you've been researching, organize your findings. If you used the TrialFinder search engine, use the built-in "Copy details" feature to generate a concise summary of a specific trial (including the NCT ID and main criteria) and print it out.

Additionally, after generating a plain-language summary for a trial you found, you can use the "Discussion Guide" feature, which creates a personalized list of questions and talking points to raise with your doctor about that specific trial.

You may also want to bring a family member or close friend to the appointment to help take notes and ask follow-up questions. This is a great way to put the advice from the guide on talking to your family into practice.

Step 2: Opening the Conversation

To keep the conversation collaborative rather than confrontational, frame your questions as a joint consultation.

Suggested opening phrases:

  • "I've been reading up on additional treatment options, and I'd love to hear your thoughts on clinical trials for my specific situation."
  • "I found some information about a clinical trial that is currently recruiting. Could we review the criteria together to see if it makes sense for me?"

Step 3: Guiding Questions to Ask

Once the door is open, here are some specific, highly effective questions to ask your doctor:

  • Regarding standard care: "How does the treatment being tested in this trial differ from the standard treatment I would receive right now?"
  • Regarding your tumor profile: "Have we tested my tumor for biomarkers or mutations, for example through a biopsy or genetic sequencing? Are there trials that match my results?"
  • Regarding timing: "If I join a clinical trial now, will it prevent me from receiving other standard treatments in the future?"

Step 4: What to Do if the Doctor Says "No"

If your doctor dismisses the idea, it's crucial to understand why.

Ask gently:

  • "Could you help me understand which medical criteria I don't meet?"
  • "Is it a safety concern, or do you believe the standard treatment is significantly better for me right now?"

If you feel the conversation didn't fully address your questions, or if the doctor simply wasn't familiar with the specific trial, seeking a Second Opinion is a normal and respected part of the process. Good doctors understand and encourage patients who want to explore every possible avenue for the best care.

Step 5: What Happens Next?

The conversation with your doctor will usually end in one of three ways:

Your doctor thinks it's a good fit. This is the best-case scenario. Your doctor can refer you directly to the trial site, contact the research coordinator on your behalf, and help with the application process. From here, they become your partner in navigating the screening phase and the trial itself. Make sure to ask what the next concrete step is and when it will happen. Before screening begins, Before You Join a Clinical Trial covers the consent form, questions worth asking, and red flags.

Your doctor says you're not a match for this specific trial. A "no" on one trial doesn't mean the door is closed. Ask your doctor specifically what made you ineligible, whether it was your disease stage, a biomarker, or a prior treatment. That information makes your next search more targeted. You can continue looking for other trials, and now that your doctor knows you're interested, they can flag new opportunities as they come up. For more on this, read Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway.

Your doctor wants to look into it. If the response is "Interesting, let me check," don't leave it open-ended. Ask when you should follow up and how (a phone call, a message through the clinic, or at your next visit). You can also ask for a referral to the trial site. If you want to reach out yourself, you can use the "Contact study team" and "Draft email to study team" features available on any trial page on TrialFinder.

A Final Note

Your medical team is your primary partner in this journey, but you have a voice in this process, and using it matters. Arriving at your appointment prepared with focused questions and organized information is a great way to take an active role in your treatment.

Related conditions

Long COVID Clinical Trials: Finding Studies for POTS, Fatigue, and Cognitive Symptoms Long COVID is not one condition. POTS, fatigue with PEM, and cognitive symptoms open different trial lists.

Alzheimer's Disease Clinical Trials: How Disease Stage and Biomarkers Shape Eligibility Alzheimer's is not one trial population. Stage and biomarkers such as amyloid and tau shape which studies may fit.

AML (Acute Myeloid Leukemia) Clinical Trials: How Genetic Mutations Shape Your Options Leukemia is not one disease. How FLT3, IDH, and NPM1 mutations, and newly diagnosed vs relapsed acute myeloid leukemia, change which trials may fit.

Epilepsy Clinical Trials: How Seizure Type and Drug Resistance Shape Eligibility Epilepsy trial options depend on seizure type and whether medicines have failed. A plain-language guide plus recruiting studies.

Brain Tumor Clinical Trials: How Tumor Type and Biomarkers Shape Eligibility Glioblastoma, lower-grade glioma, and biomarkers such as IDH and MGMT change which brain tumor trials may fit. Plain-language guide plus recruiting studies.

Further reading

Osimertinib for Uncommon EGFR Mutations: What the Evidence Shows Osimertinib (Tagrisso) for uncommon EGFR mutations such as G719X, S768I, L861Q, and exon 20 insertions: what the evidence covers, plus active clinical trials.

Clinical Trials in Mental Health: What Patients and Families Should Know Mental health clinical trials may test medication, therapy, or devices. How they differ from cancer trials, and how to start looking.

Before You Join a Clinical Trial: Screening, Informed Consent, and Red Flags Learn what screening and informed consent involve before you join a clinical trial, which questions to ask, and which red flags mean you should walk away.

The Reminder Moderna and Merck's Personalized mRNA Cancer Vaccine Gives Us About Clinical Trials Moderna and Merck's personalized mRNA vaccine met Phase 3 goals in melanoma. What that shows about joining a clinical trial.

Daraxonrasib (RASONQUE) Is Now FDA-Approved for Metastatic Pancreatic Cancer

Breast Cancer Clinical Trials: How Subtype and Biomarkers Shape Eligibility
HR+/HER2−, HER2+, and TNBC, plus biomarkers such as BRCA and PIK3CA, shape which breast cancer trials may fit. Plain-language guide plus recruiting studies.

Pancreatic Cancer Clinical Trials: How Stage and Biomarkers Shape Eligibility PDAC, resectability, and biomarkers such as KRAS, BRCA, and MSI change which pancreatic trials may fit. A plain-language guide plus recruiting studies.

Lung Cancer Clinical Trials: How Type and Biomarkers Shape Eligibility NSCLC, SCLC, and biomarkers such as EGFR, ALK, and KRAS change which lung cancer trials may fit. A plain-language guide, plus recruiting studies.

The FDA approved daraxonrasib (RASONQUE) on August 26, 2026 for metastatic pancreatic cancer after prior therapy.

Start Here: How to Search for Clinical Trials on TrialFinder A step-by-step guide to finding clinical trials on TrialFinder. Learn how to search by condition, use filters, and understand your results.

What is a Clinical Trial? (It's More Than You Think) How clinical trials work, why they matter, and what patients should know before considering one.

Not a Perfect Match? Tips for Getting Into a Clinical Trial Anyway A rejection from a clinical trial doesn't have to be the end. Practical tips for patients and caregivers who hit a wall.

How to Talk About Clinical Trials with a Family Member A guide for caregivers on introducing clinical trials to a loved one who is hesitant, tired, or afraid.

Key Clinical Trial Terms Plain-language explanations of terms patients and families encounter during the clinical trial process.

Share this post
  •  

This article was written by a patient advocate based on personal experience, not by a medical professional. It is not medical advice. Consult your doctor before making any medical decisions.

Looking for a clinical trial?

Search trials